CDC panel delays MMRV vaccine over seizure risk in toddlers


This recording was made using enhanced software.

Summary

Vaccine schedule changes

The CDC's new vaccine advisory panel voted 8-1 (with three abstentions) to postpone the recommended age for administering the combined MMRV vaccine, which protects against measles, mumps, rubella and chickenpox, from age 12 months to 4 years. Instead, children under 4 are now advised to receive separate MMR and varicella vaccines, although parents may still request the combined vaccine.

Panel membership controversy

The recent decision was made by a newly appointed CDC vaccine advisory panel, after Health Secretary Robert F. Kennedy Jr. dismissed the previous members in June and replaced them with eight new advisors. All new members are described as doctors or Ph.D. holders, but some have a history of questioning the effectiveness of proven vaccines.

Confusion within the panel

The first meeting of the newly appointed panel was reportedly marked by confusion over procedures and the implications of their decisions for health insurance coverage, according to Reuters. One panel member abstained from voting, expressing uncertainty about the vote's subject.


Full story

The CDC’s new vaccine advisory panel has made a controversial call: It has pushed back the recommended age for the combined MMRV vaccine. The vaccine protects against measles, mumps, rubella and chickenpox.

In an 8-1 vote with three abstaining, the CDC’s advisory committee said Thursday that the combined MMRV shot shouldn’t be given before age 4. That’s a change from the typical approach, where toddlers usually start at 12 months.

QR code for SAN app download

Download the SAN app today to stay up-to-date with Unbiased. Straight Facts™.

Point phone camera here

Instead, children under 4 are now advised to receive two separate shots: one for MMR and one for varicella. However, parents can still express a preference for the combined shot.

The panel was presented with new data for the vaccine that shows a slightly increased risk of febrile seizures. It’s a generally harmless side effect seen in younger toddlers when the combo shot is administered.

Critics, however, argue that the change was not about new science.

A spokesperson for Merck, which makes the combination MMRV shot, said the recent advisory committee vote and discussion “occurred in the absence of new scientific data and in contrast to years of evidence affirming the current immunization schedule.”

The vote now goes to the CDC director for final approval. Historically, that’s just a formality.

Previous panel controversy

The change comes amid Health Secretary Robert F. Kennedy Jr.’s efforts to rewrite U.S. immunization policy.

The panel that voted on the change was recently overhauled. Back in June, Kennedy dismissed the entire vaccine advisory panel, replacing them with eight new advisors.

The advisors Kennedy selected are all doctors or hold a Ph.D., but some have controversial views on vaccines. Critics contend Kennedy’s new appointees have a history of questioning vaccines that have already been proven safe and effective

Since joining the Trump administration, Kennedy has made other changes and adjustments to the nation’s health agencies. He recently defended those changes in front of Congress.

The secretary said his actions are all necessary to restore public trust in health care. Kennedy said:

“CDC failed that responsibility miserably during COVID when its disastrous, nonsensical policies destroyed small businesses, violated civil liberties, closed our schools and caused generational damage in doing so, masked infants with no science and heightened economic inequality. That’s why we need bold, competent, creative, new leadership at CDC. People able and willing to chart a new course.” 

The panel’s meeting on Thursday was the first time they’ve met since Kennedy appointed the new members.

Reuters is reporting that Thursday’s meeting was marked by points of confusion, as members asked about procedure and the impact their decisions have on health insurance coverage.

One member chose to abstain from voting and expressed confusion over what exactly he was voting for.

The panel meets again on Friday to discuss COVID and hepatitis B guidance.

Tags: , , , , , , , ,

SAN provides
Unbiased. Straight Facts.

Don't just take our word for it.


Certified balanced reporting

According to media bias experts at AllSides

AllSides Certified Balanced May 2025

Transparent and credible

Awarded a perfect reliability rating from NewsGuard

100/100

Welcome back to trustworthy journalism.

Find out more

Why this story matters

A newly reconstituted CDC vaccine advisory panel voted to change recommendations for the combined MMRV vaccine for young children, raising questions about decision-making, public trust and future U.S. vaccine policy.

Vaccine policy changes

The advisory committee's recommendation alters long-standing vaccination guidelines for children and could affect insurance coverage, public health policy and childhood disease prevention strategies nationwide.

Panel restructuring and expertise

The panel was recently replaced with members some experts say lack public health or vaccine expertise, prompting concern from public health authorities and medical organizations regarding the committee's credibility and process.

Public trust and health guidance

Several sources report that prominent medical groups and many doctors fear that the changes and process may further erode confidence in public health guidance and potentially decrease vaccine uptake among children.

Get the big picture

Synthesized coverage insights across 54 media outlets

Behind the numbers

Across the articles, about 85% of children already receive separate MMR and varicella shots for their first dose, and the risk of febrile seizures with the combined MMRV vaccine is about 8 in 10,000, compared to 4 in 10,000 for separate shots.

Context corner

The MMRV vaccine has been in use since 2005, and the debate reflects longstanding tensions between safety data, parental choice and public health priorities, with prior policies favoring flexibility to maintain high vaccination rates.

Policy impact

The ACIP’s recommendations influence which vaccines are covered by insurance, what doctors recommend and school-entry requirements, so changes can have direct impacts on vaccine access for children, particularly those relying on federal programs.

SAN provides
Unbiased. Straight Facts.

Don't just take our word for it.


Certified balanced reporting

According to media bias experts at AllSides

AllSides Certified Balanced May 2025

Transparent and credible

Awarded a perfect reliability rating from NewsGuard

100/100

Welcome back to trustworthy journalism.

Find out more

Bias comparison

  • Media outlets on the left frame the ACIP panel’s recommendation against the combined MMRV vaccine for children under 4 as a politically fraught shift undermining scientific integrity, emphasizing RFK Jr.’s “hand-picked” advisers and highlighting “controversy” and risks of public confusion.
  • Not enough unique coverage from media outlets in the center to provide a bias comparison.
  • Media outlets on the right portray the move as a cautious, “precautionary” adjustment to vaccine policy, praising Kennedy’s “overhaul” as restoring confidence and stressing the overall “safety” of vaccines, with less focus on political tension.

Media landscape

Click on bars to see headlines

54 total sources

Key points from the Left

  • A panel voted 8-1 to recommend that children under four should not receive the MMRV vaccine due to risks of febrile seizures, as reported by the Advisory Committee on Immunization Practices.
  • The recommendations may impact vaccine coverage under the Children's Health Insurance Program and Medicaid, although they will not affect the Vaccines for Children program.
  • Secretary Robert F. Kennedy Jr. made significant changes to the panel, replacing members, which has raised concerns about potential decreases in vaccination rates and disregarding scientific data.
  • Some new members of the Advisory Committee on Immunization Practices have a history of criticism regarding vaccines, leading to accusations of unqualified selections by former CDC directors.

Report an issue with this summary

Key points from the Center

No summary available because of a lack of coverage.

Report an issue with this summary

Key points from the Right

  • The CDC Advisory Committee on Immunization Practices voted 8-1 to no longer recommend the MMRV vaccine for children under 4 years old.
  • Concerns regarding the risk of fever-induced seizures related to the MMRV vaccine influenced the panel's decision.
  • The Advisory Committee on Immunization Practices suggested separate vaccinations for chickenpox and measles, mumps and rubella.
  • ACIP must finalize the recommendations after approval from CDC acting director Jim O'Neill.

Report an issue with this summary

Powered by Ground News™